News

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic non-small cell lung…
Read More...

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has entered…
Read More...

GentiBio, Inc., an engineered regulatory T cells (Tregs) company,  announced that it has entered into a collaboration with Bristol Myers Squibb to develop new engineered Treg therapies…
Read More...

Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, announced that the U.S. Food and Drug Administration (FDA) granted Orphan…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

Gilead Sciences, Inc. and MiroBio announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire MiroBio for approximately $405 million in…
Read More...

Acadia Pharmaceuticals Inc. announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug…
Read More...

Poseida Therapeutics, Inc. announced it has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to…
Read More...

Sinovac Biotech Ltd. announced that based on related clinical trials and studies of vaccination for local children and adolescents, the Health Bureau of the Government of the Hong Kong…
Read More...

Radiopharm Theranostics, a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that it has entered a…
Read More...

Kiniksa Pharmaceuticals, Ltd. announced a global license agreement with Roche and Genentech, a member of the Roche Group (Genentech), for the rights to develop and commercialize…
Read More...

Sosei Group Corporation announce they have entered a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules that…
Read More...

Rigel Pharmaceuticals, Inc. and Forma Therapeutics, Inc. announced that they have entered into an exclusive, worldwide license agreement to develop, manufacture and commercialize…
Read More...

Synthego announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that…
Read More...

TransCode Therapeutics, Inc. the RNA oncology company, and The University of Texas MD Anderson Cancer Center (“MD Anderson”), announced a strategic alliance to advance TransCode’s…
Read More...

Gamida Cell Ltd.  announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment…
Read More...

Xeris Biopharma Holdings, Inc. announced that Tetris Pharma—its commercialization partner for Ogluo in the UK, EEA, and Switzerland—will be acquired by Arecor Therapeutics (AIM: AREC),…
Read More...

Krystal Biotech, Inc. announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate KB407 in a clinical…
Read More...

GreenLight Biosciences and Samsung Biologics announced the successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Since…
Read More...